Mitumomab is an anti-BEC-2 monoclonal antibody derived from mice, previously studied for small cell lung carcinoma treatment in combination with BCG vaccination. The DrugMonitor™ Anti-Mitumomab Antibody (VS-1224-YC754) is an anti-drug antibody (ADA) against Mitumomab. This drug-based antibody is raised in mice immunized with the Mitumomab. The anti-Mitumomab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Mitumomab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Afuco™ Anti-ST8SIA1 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-764)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant mouse monoclonal antibody expressed in CHO binding to human ganglioside GD3. It is a mouse monoclonal antibody investigated for the treatment of small cell lung carcinoma in combination with BCG vaccination.
There are currently no Customer reviews or questions for VS-1224-YC754. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.